A Multi-Centre, Randomised, Double-Blinded, Placebo Controlled, Parallel Group, Multiple Dose Study of the Efficacy of 8.75mg Flurbiprofen Spray in the Relief of Sore Throat due to URTI.
Year: 2012
Type: Pharmaceutical - Other
Phase: III
Indication: Other
A Randomized, Double-Blind, Parallel-Group, Placebo- and Active- Controlled, Multi-center Study to Evaluate the Efficacy, Safety and Tolerability of Combinations of Solifenacin Succinate and Mirabegron Compared to Solifenacin Succinate and Mirabegron Monotherapy in the Treatment of Overactive Bladder.
Year: 2013
Type: Pharmaceutical - Other
Phase: III
Indication: Overactive Bladder
A Randomized, Double-Blind, Parallel-Group, Active-Controlled, Multi-center Study to Evaluate the Long-Term Safety and Efficacy of Combination of Solifenacin Succinate with Mirabegron Compared to Solifenacin Succinate and Mirabegron Monotherapy in Subjects with Overactive Bladder.
Year: 2013
Type: Pharmaceutical - Other
Phase: III
Indication: Overactive Bladder
A randomized, double-blind, placebo-controlled study of the safety and efficacy of AA4500 for the treatment of adhesive capsulitis of the shoulder.
Year: 2014
Type: Musculoskeletal
Phase: IIb
Indication: Other
An Open-label Historically Controlled Study to Assess the Safety and Efficacy of Two Concurrent Injections of AA4500 in Adult Subjects with Multiple Dupuytren’s Contractures with Palpable Cords.
Year: 2012
Type: Musculoskeletal
Phase: IIIb
Indication: Other
Dose-Ranging Study of Multiple Subcutaneous Doses of LY2127399, an Anti-BAFF Human Antibody, in Participants with Active Rheumatoid Arthritis despite Ongoing Methotrexate Therapy.
Year: 2010
Type: Musculoskeletal
Phase: II
Indication: Rheumatoid Arthritis
A Study to Compare the Preference for Two Contrasting Paracetamol Formulations In The Management of Osteoarthritis Pain.
Year: 2008
Type: Musculoskeletal
Phase: IV
Indication: Knee Osteoarthritis
A Multi-Centre, Randomised, Double-Blind, Placebo Controlled, Parallel Group Exploratory Study to Investigate the Efficacy, Safety and Tolerability of AD 337 in the Treatment of Fibromyalgia in Female Subjects.
Year: 2007
Type: Musculoskeletal
Phase: II
Indication: Fibromyalgia
A Randomised, Double-Blinded Study to Assess Safety, Immunogenicity, and Lot Consistency of Solvay’s Cell Derived Influenza Vaccine.
Year: 2010
Type: Vaccine
Phase: III
Indication: Healthy
A Randomized, Observer-Blind with Single-Blind Booster, Multi Centre, Study to Evaluate Safety, Tolerability and Immunogenicity of an Adjuvanted Cell Culture-Derived H5N1 Subunit Influenza Virus Vaccine at Two Different Formulations in Healthy Adult and Elderly Subjects.
